Worth Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
LMFP
HCM
AAMU
HPC
CRM
CNB
Worth Asset Management's ABBV Position: Q2 2026 in Review
Worth Asset Management increased its AbbVie (ABBV) stake by 15% in Q2 2026, buying an estimated $51K and bringing the position to 1,863 shares worth $469K. The position accounts for 0.15% of the portfolio, ranked #120.
Worth Asset Management first reported a position in ABBV in Q1 2022 and has held it in 18 quarters since. The position peaked at $2.22M in Q3 2024. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Worth Asset Management held 1,863 shares of AbbVie worth $469K as of Q2 2026.
- Worth Asset Management bought 237 AbbVie shares in Q2 2026, an estimated $51K.
- AbbVie made up 0.15% of Worth Asset Management's portfolio in Q2 2026, its #120 holding.
- Worth Asset Management first reported a position in AbbVie in Q1 2022 and has held it in 18 quarters since.
- Worth Asset Management's AbbVie position peaked at $2.22M in Q3 2024.
- 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Worth Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.